Developer docs
API playgroundTry for free, no card

Search company profiles

MECTA LTD

Full company profile

uuid025nsfv

Namestring
MECTA LTD
Legal namestring
MECTA LLC
Company typeenum
Private
Founded yearint
1980
Descriptiontext

MECTA LTD, operating legally as MECTA LLC (formerly MECTA Corporation), is a privately held US medical device manufacturer specializing in electroconvulsive therapy (ECT) equipment. Founded as a trade name in continuous operation since 1938 and headquartered in the Portland, Oregon area, the company designs and produces the FDA-approved MECTA spECTrum and MECTA Σigma ECT devices, which deliver controlled electrical pulses to induce therapeutic seizures for patients with severe, treatment-resistant psychiatric conditions including major depression, bipolar disorder, and psychotic illnesses such as schizophrenia. The core product line includes both 100 Joule (DOM) and 200 Joule (INT) device configurations, along with optional accessories, replacement parts, and post-sale technical service.

The company sells exclusively to licensed health providers and hospitals — it does not sell to or interact directly with patients. In the United States and Canada, MECTA operates a direct sales model with phone-based customer service during Pacific Standard Time business hours; internationally, it routes customers through a network of local distributor representatives. Revenue is generated through hardware sales (devices and accessories), recurring service and technical support contracts, and ancillary educational offerings including the International Course on Electroconvulsive Therapy, clinician training programs, fellowships, and the Patients & Families Information Booklet bundled with each device. The company maintains a modest direct footprint and relies on academic and clinical partners — including Dartmouth-Hitchcock Medical Center, Sutter Health, Resnick Neuropsychiatric Hospital, and Menninger Clinic — for educational content and clinical training support.

Short descriptiontext

MECTA LTD (legal entity MECTA LLC) manufactures FDA-approved electroconvulsive therapy devices — the MECTA spECTrum and MECTA Σigma — for treatment-resistant psychiatric conditions, selling exclusively to licensed health providers and hospitals via direct US/Canada sales and international distributors.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersTualatin, United States
HQ citystring
Tualatin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
electroconvulsive therapy devices, psychiatric medical devices, ECT device manufacturing, clinical ECT training, medical device service
Industry1 code
PRIMARYCRACAQAL
Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Psychiatric Medical Devices
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1ECT Device Sales
TypeHardware Sales
Description

MECTA manufactures and sells ECT devices to licensed healthcare providers and hospitals. The company also provides service and technical support for their devices.

mectaspectrum.com
2Device Accessories and Parts
TypeHardware Sales
Description

Sale of optional accessories for the MECTA spECTrum device. Part numbers referenced include DOM (100 Joule): 9900-1021 and INT (200 Joule): 9900-1018.

mectaspectrum.com
3Service and Technical Support
TypeProfessional Services
Description

Post-sale technical assistance, diagnostic services, and support for device owners.

mectaspectrum.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1MECTA Σigma
Description

ECT device product line

mectaspectrum.com
Core offering1 text field

MECTA manufactures and sells FDA-approved electroconvulsive therapy (ECT) devices, including the MECTA spECTrum and MECTA Σigma systems, along with optional accessories and clinician training resources. The company sells exclusively to licensed health providers and hospitals for the treatment of severe psychiatric disorders such as major depression, bipolar disorder, and psychotic illnesses. Post-sale technical service and international distribution are provided through a combination of direct U.S./Canada support and a network of international distributor representatives.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • ECT associated with 50 percent reduction in risk for suicide among patients with depression in the year after hospitalization (CAMH and ICES study of over 67,000 patients)
+1 more record
Product overview1 text field

MECTA LTD is a medical device manufacturer that produces electroconvulsive therapy (ECT) devices for psychiatric treatment. The company's core product line includes the MECTA spECTrum device and MECTA Σigma device, sold to licensed health providers and hospitals. The product portfolio also includes optional accessories, the Patients & Families Information Booklet (included with device purchase), and professional training programs including the International Course on ECT. The company provides device service and technical support through its Service program.

Product and service7 records
1MECTA spECTrum ECT Device
CategoryElectroconvulsive Therapy Device (Core Hardware)
Description

FDA-approved electroconvulsive therapy (ECT) device used by licensed healthcare providers and hospitals to deliver controlled electrical pulses that induce therapeutic seizures for treatment-resistant major depression, bipolar disorder, and psychotic illnesses such as schizophrenia.

2MECTA spECTrum Optional Accessories
CategoryDevice Accessories
Description

Optional accessories and components used to support the operation of the MECTA spECTrum ECT device in clinical settings.

3MECTA Σigma ECT Device
CategoryElectroconvulsive Therapy Device (Core Hardware)
Description

ECT device model available in DOM (100 Joule) and INT (200 Joule) configurations for clinical use by licensed healthcare providers.

4MECTA Service and Technical Support
CategoryTechnical Service and Support
Description

Post-sale technical support, diagnostics, and service for MECTA ECT device owners, delivered directly in the U.S. and Canada and through international distributor representatives elsewhere.

5ECT Training Programs and Fellowships
CategoryClinical Education and Training
Description

Clinical training programs and fellowships covering ECT procedures and best practices, offered to clinicians administering or supporting ECT in licensed facilities.

6International Course on Electroconvulsive Therapy
CategoryClinical Education and Training
Description

Professional educational course covering ECT practices and clinical applications, targeted at international clinicians involved in ECT administration.

7Patients and Families Information Booklet
CategoryPatient Education Material
Description

Educational booklet covering who should receive ECT, how it works, effects on thinking and memory, and physical risks; provided with every MECTA device purchase and available for separate purchase to inform patients and families.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership2 partners
1International Distributor Representatives
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

MECTA has a network of international distributor representatives who provide service support, technical assistance, and distribution of MECTA ECT devices in countries outside the U.S. and Canada.

mectaspectrum.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Produced an educational ECT DVD under exclusive distribution from MECTA Corporation. This partnership provides educational content about electroconvulsive therapy for patient and clinician education.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

Public neuromodulation and cardiac device company whose vagus nerve stimulation (VNS) therapy is FDA-approved for treatment-resistant depression. A broader incumbent that competes with ECT in the refractory depression segment via an implantable modality.

TypeEmerging player
Description

European maker of an at-home transcranial direct current stimulation (tDCS) device marketed for depression. Targets the same patient segment as ECT with a non-clinical, lower-stigma delivery model.

TypeDirect peer
Description

Manufacturer of the Thymatron, the leading direct competitor to MECTA's spECTrum ECT device. Both companies sell FDA-cleared electroconvulsive therapy devices to hospitals and psychiatric clinics for treatment-resistant depression and severe psychiatric conditions.

TypeEmerging player
Description

Developer of deep transcranial magnetic stimulation (Deep TMS) systems cleared by the FDA for major depressive disorder and OCD. A direct alternative modality to ECT for the same treatment-resistant population MECTA addresses.

TypeEmerging player
Description

Commercial-stage developer of the NeuroStar TMS system, FDA-cleared for treatment-resistant depression. Competes with MECTA for the same psychiatric patient population via a less-stigmatized, non-convulsive modality.

6Magstim
TypeDirect peer
Description

UK-based manufacturer of neurostimulation devices spanning ECT and transcranial magnetic stimulation (TMS). Directly comparable as a clinical-grade electrotherapeutic apparatus maker targeting the same psychiatric and neuroscience end-markets as MECTA.

7Apollo Neuroscience
TypeEmerging player
Description

Consumer wearable neurostimulation device maker focused on stress, sleep and anxiety. Operates in the same underlying neurostimulation technology category as MECTA but positioned for consumer mental wellness rather than clinical psychiatric care.

TypeEmerging player
Description

Manufacturer of a consumer-grade cranial electrotherapy stimulation (CES) device for depression, anxiety and insomnia. Overlaps with MECTA's neurostimulation category but in a consumer/prescription-adjacent positioning.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MECTA LTD

Psychiatric Medical Devicesmectaspectrum.com

MECTA LTD (legal entity MECTA LLC) manufactures FDA-approved electroconvulsive therapy devices — the MECTA spECTrum and MECTA Σigma — for treatment-resistant psychiatric conditions, selling exclusively to licensed health providers and hospitals via direct US/Canada sales and international distributors.

What MECTA LTD does

MECTA LTD, operating legally as MECTA LLC (formerly MECTA Corporation), is a privately held US medical device manufacturer specializing in electroconvulsive therapy (ECT) equipment. Founded as a trade name in continuous operation since 1938 and headquartered in the Portland, Oregon area, the company designs and produces the FDA-approved MECTA spECTrum and MECTA Σigma ECT devices, which deliver controlled electrical pulses to induce therapeutic seizures for patients with severe, treatment-resistant psychiatric conditions including major depression, bipolar disorder, and psychotic illnesses such as schizophrenia. The core product line includes both 100 Joule (DOM) and 200 Joule (INT) device configurations, along with optional accessories, replacement parts, and post-sale technical service.

The company sells exclusively to licensed health providers and hospitals — it does not sell to or interact directly with patients. In the United States and Canada, MECTA operates a direct sales model with phone-based customer service during Pacific Standard Time business hours; internationally, it routes customers through a network of local distributor representatives. Revenue is generated through hardware sales (devices and accessories), recurring service and technical support contracts, and ancillary educational offerings including the International Course on Electroconvulsive Therapy, clinician training programs, fellowships, and the Patients & Families Information Booklet bundled with each device. The company maintains a modest direct footprint and relies on academic and clinical partners — including Dartmouth-Hitchcock Medical Center, Sutter Health, Resnick Neuropsychiatric Hospital, and Menninger Clinic — for educational content and clinical training support.

MECTA LTD firmographics

Firmographics
Name
MECTA LTD
Legal name
MECTA LLC
Website
https://mectaspectrum.com
Company type
Private
Founded year
1980
Operating status
Operating
Short description
MECTA LTD (legal entity MECTA LLC) manufactures FDA-approved electroconvulsive therapy devices — the MECTA spECTrum and MECTA Σigma — for treatment-resistant psychiatric conditions, selling exclusively to licensed health providers and hospitals via direct US/Canada sales and international distributors.
Ownership category
akta.pro rank

MECTA LTD industry classification

Industry
Product category
Psychiatric Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYCRACAQAL
Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)

Keywords

  • Electroconvulsive therapy devices
  • Psychiatric medical devices
  • ECT device manufacturing
  • Clinical ECT training
  • Medical device service

Where MECTA LTD is headquartered

Location

Headquarters

HQ city
Tualatin
HQ country
United States
HQ region
North America

Offices1 record

Markets served

MECTA LTD business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. ECT Device Sales: MECTA manufactures and sells ECT devices to licensed healthcare providers and hospitals. The company also provides service and technical support for their devices.
  2. Device Accessories and Parts: Sale of optional accessories for the MECTA spECTrum device. Part numbers referenced include DOM (100 Joule): 9900-1021 and INT (200 Joule): 9900-1018.
  3. Service and Technical Support: Post-sale technical assistance, diagnostic services, and support for device owners.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

MECTA LTD product offering

Product offering

Core offering

MECTA manufactures and sells FDA-approved electroconvulsive therapy (ECT) devices, including the MECTA spECTrum and MECTA Σigma systems, along with optional accessories and clinician training resources. The company sells exclusively to licensed health providers and hospitals for the treatment of severe psychiatric disorders such as major depression, bipolar disorder, and psychotic illnesses. Post-sale technical service and international distribution are provided through a combination of direct U.S./Canada support and a network of international distributor representatives.

Product overview

MECTA LTD is a medical device manufacturer that produces electroconvulsive therapy (ECT) devices for psychiatric treatment. The company's core product line includes the MECTA spECTrum device and MECTA Σigma device, sold to licensed health providers and hospitals. The product portfolio also includes optional accessories, the Patients & Families Information Booklet (included with device purchase), and professional training programs including the International Course on ECT. The company provides device service and technical support through its Service program.

Differentiator

Problem solved

Functional benefit

Brands

  • MECTA Σigma: ECT device product line

Products and services

  • MECTA spECTrum ECT Device FDA-approved electroconvulsive therapy (ECT) device used by licensed healthcare providers and hospitals to deliver controlled electrical pulses that induce therapeutic seizures for treatment-resistant major depression, bipolar disorder, and psychotic illnesses such as schizophrenia.
  • MECTA spECTrum Optional Accessories Optional accessories and components used to support the operation of the MECTA spECTrum ECT device in clinical settings.
  • MECTA Σigma ECT Device ECT device model available in DOM (100 Joule) and INT (200 Joule) configurations for clinical use by licensed healthcare providers.
  • MECTA Service and Technical Support Post-sale technical support, diagnostics, and service for MECTA ECT device owners, delivered directly in the U.S. and Canada and through international distributor representatives elsewhere.
  • ECT Training Programs and Fellowships Clinical training programs and fellowships covering ECT procedures and best practices, offered to clinicians administering or supporting ECT in licensed facilities.
  • International Course on Electroconvulsive Therapy Professional educational course covering ECT practices and clinical applications, targeted at international clinicians involved in ECT administration.
  • Patients and Families Information Booklet Educational booklet covering who should receive ECT, how it works, effects on thinking and memory, and physical risks; provided with every MECTA device purchase and available for separate purchase to inform patients and families.

Quantifiable outcome

  • ECT associated with 50 percent reduction in risk for suicide among patients with depression in the year after hospitalization (CAMH and ICES study of over 67,000 patients)
  • +1 more outcomes

Companies that use MECTA LTD

Customer profile

Named customers5 records

Segments1 record

Ideal customer profiles1 record

MECTA LTD technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

MECTA LTD partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • International Distributor RepresentativescoreChannel Partner/ Reseller/ DistributorMECTA has a network of international distributor representatives who provide service support, technical assistance, and distribution of MECTA ECT devices in countries outside the U.S. and Canada.
  • Dartmouth-Hitchcock Medical CenterminorStrategic or Co-development PartnerProduced an educational ECT DVD under exclusive distribution from MECTA Corporation. This partnership provides educational content about electroconvulsive therapy for patient and clinician education.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

MECTA LTD competitors and assessment

Company assessment

Broad incumbents

  • LivaNova: Public neuromodulation and cardiac device company whose vagus nerve stimulation (VNS) therapy is FDA-approved for treatment-resistant depression. A broader incumbent that competes with ECT in the refractory depression segment via an implantable modality.

Emerging players

  • Flow Neuroscience: European maker of an at-home transcranial direct current stimulation (tDCS) device marketed for depression. Targets the same patient segment as ECT with a non-clinical, lower-stigma delivery model.
  • Brainsway: Developer of deep transcranial magnetic stimulation (Deep TMS) systems cleared by the FDA for major depressive disorder and OCD. A direct alternative modality to ECT for the same treatment-resistant population MECTA addresses.
  • Neuronetics: Commercial-stage developer of the NeuroStar TMS system, FDA-cleared for treatment-resistant depression. Competes with MECTA for the same psychiatric patient population via a less-stigmatized, non-convulsive modality.
  • Apollo Neuroscience: Consumer wearable neurostimulation device maker focused on stress, sleep and anxiety. Operates in the same underlying neurostimulation technology category as MECTA but positioned for consumer mental wellness rather than clinical psychiatric care.
  • Fisher Wallace: Manufacturer of a consumer-grade cranial electrotherapy stimulation (CES) device for depression, anxiety and insomnia. Overlaps with MECTA's neurostimulation category but in a consumer/prescription-adjacent positioning.

Direct peers

  • Somatics LLC: Manufacturer of the Thymatron, the leading direct competitor to MECTA's spECTrum ECT device. Both companies sell FDA-cleared electroconvulsive therapy devices to hospitals and psychiatric clinics for treatment-resistant depression and severe psychiatric conditions.
  • Magstim: UK-based manufacturer of neurostimulation devices spanning ECT and transcranial magnetic stimulation (TMS). Directly comparable as a clinical-grade electrotherapeutic apparatus maker targeting the same psychiatric and neuroscience end-markets as MECTA.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

MECTA LTD financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MECTA LTD leadership team

Management profile

Number of profiles

MECTA LTD funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MECTA LTD M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MECTA LTD

What does MECTA LTD do?

MECTA manufactures and sells FDA-approved electroconvulsive therapy (ECT) devices, including the MECTA spECTrum and MECTA Σigma systems, along with optional accessories and clinician training resources. The company sells exclusively to licensed health providers and hospitals for the treatment of severe psychiatric disorders such as major depression, bipolar disorder, and psychotic illnesses. Post-sale technical service and international distribution are provided through a combination of direct U.S./Canada support and a network of international distributor representatives.

Is MECTA LTD a public or private company?

MECTA LTD is a private company. It is classified as unknown and is currently operating.

When was MECTA LTD founded?

MECTA LTD was founded in 1980.

Where is MECTA LTD based?

MECTA LTD is headquartered in Tualatin, United States, in the North America region.

How does MECTA LTD make money?

Three revenue lines are on record. ECT Device Sales are the primary driver. The others are device Accessories and Parts and service and Technical Support.

Who are MECTA LTD's main competitors?

LivaNova is listed as a broad incumbent. Emerging players are Flow Neuroscience, Brainsway, Neuronetics, Apollo Neuroscience and Fisher Wallace. Direct peers are Somatics LLC and Magstim.

Does MECTA LTD have an API?

No public API is recorded for MECTA LTD.

What industry is MECTA LTD in?

MECTA LTD's product category is Psychiatric Medical Devices. Its primary akta.pro industry code is CRACAQAL, Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales